NATIONAL NEWS

Federal health officials push effort to spur cheaper biotech drugs

Oct 29, 2025, 12:12 PM

FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in ...

FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)
Credit: ASSOCIATED PRESS

(AP Photo/Jose Luis Magana, File)

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.

The Food and Drug Administration said Wednesday it has released guidance to simplify studies for biologic drugs and cut unnecessary testing.

Biologic drugs are made from living cells instead of by mixing chemicals. They have led to major advances in treating immune system disorders, eye diseases and some cancers since the late 1990s, but they also are very costly.

For decades, biotech drugmakers argued that their medicines were too complex to be copied by competitors. That finally changed under President Barack Obama’s 2010 health overhaul, which ordered the FDA to create a system for approving “biosimilar drugs.” The industry term arose because scientists insisted it would be impossible to produce exact copies of their biotech drugs.

FDA’s pathway, finally published in 2015, suggests that drugmakers conduct studies showing patients respond similarly to biosimilar versions when compared with the originals.

The latest proposal seeks to ease that standard, which the administration calls an “unnecessary resource-intensive requirement.”

“The result will be more competition, lower prices and faster access to lifesaving medicines,” said Health Secretary Robert F. Kennedy Jr.

The draft guidance is the first step in an extensive bureaucratic process. It amounts to a tentative set of recommendations for drugmakers.

The FDA will take public comments on its proposal for 60 days. After that, it must review and revise the document. The final guidance, expected in three months to six months, will not be binding. It will serve as suggestions for drugmakers working on biosimilars.

Biosimilar competition has brought some price relief to patients who take such drugs such as the autoimmune disease treatment Humira. But this may not happen immediately. That can depend on insurance coverage and whether the biosimilar is added to a pharmacy benefit manager’s list of covered drugs.

Experts say that over time, biosimilars also can prompt drugmakers to lower the cost of their biologic drugs or offer bigger rebates to keep their product on a formulary.

___

Associated Press writer Ali Swenson contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Please follow our Community Guidelines

National News

Philadelphia 76ers forward LeBron James (23) signals a teammate against the Detroit Pistons in the ...

Associated Press

LeBron James sues makers of AI sports-betting app, saying they used his likeness and nickname

NBA superstar LeBron James sued the makers of an AI sports-betting app Tuesday, saying they have deliberately violated his publicity rights and trademarks by calling it “Bron” and using artificially generated images of him in their marketing. In a lawsuit filed in U.S. District Court in New York, James’ attorneys called it “a willful, bad-faith […]

14 minutes ago

FILE - This image provided by the Justice Department, contained in the complaint supporting the arr...

Associated Press

Man gets more than 27 years in US prison for assassination plot that he said was steered from Iran

NEW YORK (AP) — A man who admitted trying to get a U.S. politician killed — and said Iran’s paramilitary Revolutionary Guard drove him to it — was sentenced Tuesday to nearly three decades in prison. Asif Merchant, a Pakistani businessman, had faced the possibility of life in prison for what the judge called an […]

42 minutes ago

US measles mexico...

Mike Stobbe and Devi Shastri, The Associated Press

Sen. Patty Murray criticizes Trump, RFK Jr. as U.S. and Mexico lose measles elimination status

U.S. Senator Patty Murray released a statement directed at President Trump and RFK Jr. in response to the U.S. losing its measles-free status.

45 minutes ago

Planes are parked at Harry Reid International Airport during a nationwide ground stop, Friday, Nov....

Associated Press

Trump faces criticism as allies press the White House for answers on tech problems

President Donald Trump faced a groundswell of criticism Tuesday as friends and foes alike said the White House must answer for a cascade of service outages that snarled travel, cut off work, limited bank access and disrupted classified communications. Even staunch Trump allies accused the administration of lying to Americans or hiding information about the […]

1 hour ago

House Minority Leader Hakeem Jeffries, D-N.Y., departs after discussing his agenda during a news co...

Associated Press

House Democrats prepare to elect leaders for the new Congress as party pushes for change

WASHINGTON (AP) — House Democrats are preparing to elect their leadership slate for the new Congress in closed-door meetings this week that will test Democratic leader Hakeem Jeffries and the generation of new leaders who are running to take charge of their new majority. Jeffries, with Rep. Katherine Clark of Massachusetts, and Rep. Pete Aguilar […]

1 hour ago

FILE - Signs promoting 5G wireless technology from Chinese technology firm Huawei are displayed at ...

Associated Press

In closings, Chinese tech giant Huawei is cast by prosecutors as a villain as its lawyer disagrees

NEW YORK (AP) — The racketeering conspiracy trial of Huawei Technologies approached its end Tuesday after a prosecutor told jurors that the Chinese telecommunications giant helped Iran spy on its citizens and steal from U.S. companies and a defense lawyer accused the U.S. of embracing a false narrative. Defense attorney Brian Heberlig said in a […]

2 hours ago

Federal health officials push effort to spur cheaper biotech drugs